Glutathione peroxidase

New Research Shows Potential Role for Mangos in Supporting Vascular Health and Antioxidant Activities

Retrieved on: 
Tuesday, August 1, 2023
SOD, GPX, United States National Library of Medicine, MedlinePlus, Mineral, PMID, Diet, College, American Society for Nutrition, VCAM1, Stroke, Public, Vascular disease, DV, VCAM-1, Nutrient, Woman, Risk, Glutathione peroxidase, Vitamin, National library, Oxidative stress, SOD1, Hydrogen peroxide, Superoxide dismutase, MD, Water, School, Phytochemical, Overweight, Copper, Antioxidants & Redox Signaling, Health, Science and technology in Asia, Death, Society, Conference, Disease, San Diego State University, Dietary supplement, Vaccine, Research, Exercise

BOSTON, Aug. 1, 2023 /PRNewswire/ -- Mangos are one of the most popular fruits1 in the world, grown in more than 100 countries2 globally and consumed by an extremely diverse population. Now, two new studies funded by the National Mango Board and presented as posters during the American Society for Nutrition's Annual Conference (Nutrition 2023) show mangos may play a role in risk reductions for vascular issues while helping to improve antioxidant levels among relatively healthy adult men and women who are overweight or obese.

Key Points: 
  • Mangos are one of the most popular fruits in the world, grown in 100+ countries and consumed by a diverse population.
  • "It's likely the unique matrix of vitamins and bioactive compounds synergistically working together that resulted in our findings," says Young Hong.
  • Following the first 12 weeks, participants took a 4-week washout break then switched groups and consumed the alternate snack for another 12 weeks.
  • Findings from the second study show a significant increase of glutathione peroxidase (GPX), a powerful antioxidant enzyme.

Wellbeing Subsidiary KGK Science Announces Successful Results of UP360, a Nutraceutical Ingredient Demonstrating Beneficial Immune Defense Response

Retrieved on: 
Wednesday, May 3, 2023
Alternative Medicine, Health, Finance, Other Health, Small Business, Pharmaceutical, Professional Services, Other Science, Mental Health, Research, Infectious Diseases, General Health, Science, Clinical Trials, Aloe vera, Therapy, Bureau of Oceans and International Environmental and Scientific Affairs, Vaccination, Frontiers, Estrone (medication), FRA, Glutathione peroxidase, Trial of the century, TCR, MEDI, Risk, Lower respiratory tract infection, Immune system, OTC, SQ2, NEO, Vaccine, Nutrition

The resultant proprietary blend of these botanical ingredients in UP360 produces antioxidant, anti-inflammatory, and immunomodulatory effects.

Key Points: 
  • The resultant proprietary blend of these botanical ingredients in UP360 produces antioxidant, anti-inflammatory, and immunomodulatory effects.
  • This is the first study to examine a proprietary combination of these ingredients using a human vaccine model.
  • The randomized, triple-blind, placebo-controlled clinical trial involving supplementation with UP360 provides evidence for a robust, healthy immune response in adults following influenza vaccination.
  • “UP360 supplementation provided a beneficial immune defense response and improved antioxidant function in conjunction with traditional vaccination, adopted by many as part of their overall immune health strategy,” says Dr. Corey Hilmas, Chief Scientific Affairs and Regulatory Officer at KGK Science.

Wellbeing Subsidiary KGK Science Announces Successful Results of UP446, a Nutraceutical Ingredient, in Positive Immune Defense Response

Retrieved on: 
Tuesday, December 6, 2022
Biotechnology, Alternative Medicine, Professional Services, Health, General Health, Pharmaceutical, Small Business, Research, Science, Clinical Trials, Finance, Publication, Therapy, Immunoglobulin G, Vaccination, MEDI, Dietary supplement, Estrone (medication), OTC, Digital Science, Science, Immunoglobulin A, KGK, Patient, Glutathione peroxidase, Respiratory tract, NEO, Research, GMP, Nutrient, Drug development, Scutellaria baicalensis, Trial of the century, Ageing, Safety, Marketing, Database, FRA, Patent, SQ2, Risk, Vaccine, Pharmaceutical industry, Scutellaria

The randomized, triple-blind, placebo-controlled clinical trial involving supplementation with bioflavonoid composition UP446 provides evidence for a robust, healthy immune response in adults following influenza vaccination.

Key Points: 
  • The randomized, triple-blind, placebo-controlled clinical trial involving supplementation with bioflavonoid composition UP446 provides evidence for a robust, healthy immune response in adults following influenza vaccination.
  • Healthy adult participants, who had not yet received their influenza vaccine, between 40-80 years of age were randomized to either UP446 or placebo for 56 days.
  • Influenza-specific IgG antibodies significantly increased with UP446 supplementation from Day 28 to 56 and from baseline at Day 56.
  • Using a vaccine model provided a unique and novel way to examine the effect of UP446 supplementation on the immune response.

Meniere's Disease Pipeline Research Report 2021: Comprehensive Insights About 10+ Companies and 10+ Pipeline Drugs - ResearchAndMarkets.com

Retrieved on: 
Thursday, November 25, 2021
Health, Clinical Trials, Patient, Lung, News, Discovery, Retina, Fibrosis, Tinnitus, Technology, Brain, Acquisition, GPX, Disease, Kidney, Clinical trial, Mergers and acquisitions, Therapy, Ototoxicity, NDA, Fast Track, Sensorineural hearing loss, III, FDA, Cystic fibrosis, Neuropsychiatric Disease and Treatment, Glutathione peroxidase, Lists of diseases, II, Dietary supplement, Pharmaceutical industry

This "Meniere's Disease - Pipeline Insight, 2021," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Meniere's Disease pipeline landscape.

Key Points: 
  • This "Meniere's Disease - Pipeline Insight, 2021," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Meniere's Disease pipeline landscape.
  • A detailed picture of the Meniere's Disease pipeline landscape is provided which includes the disease overview and Meniere's Disease treatment guidelines.
  • The assessment part of the report embraces, in depth Meniere's Disease commercial assessment and clinical assessment of the pipeline products under development.
  • The companies and academics are working to assess challenges and seek opportunities that could influence Meniere's Disease R&D.